With the exception of Cer1P in cell lines, which exhibited a significant gradual increase, no significant variations in lipid profiles were observed across the different AD stages, excluding a gradually increasing tendency in the levels of the Sph and total Cer. This evidence concerns the gene CBLN1 and Alzheimer disease.